Renegotiating NAFTA – Implications for the Health Sector – Aug 22

  • Renegotiating NAFTA – Implications for the Health Sector
    August 22, 2017
    12:00 pm - 1:30 pm

As the US Government moves towards a renegotiation of the NAFTA agreement, what is at stake for U.S. pharmaceutical, device and med-tech industries? Please join us for a discussion on where the negotiations currently stand, and a review of the possible benefits and costs to the health sector.

Box lunch will be provided


Jodi Bond
Senior Vice President, Americas, U.S. Chamber of Commerce






Kelly Ann Shaw
Trade Counsel, U.S. House of Representatives Committee on Ways and Means




David Talbot
Senior Advisor, Eli Lilly

David Talbot currently serves as Senior Director of International Government Affairs at Eli Lilly and Company. He provides government affairs support to Lilly’s operations in Europe and Canada. Previously, he supported Lilly’s operations in Latin America, the Middle East, Africa, Turkey and Russia. He also oversees Lilly’s corporate affairs capabilities training program for international affiliates and supports Lilly executive engagement in Government Affairs both domestically and internationally.

In 2016, David served as the Senior Advisor for U.S. Alzheimer’s Environmental Readiness at Lilly. He led an initiative called the Alzheimer’s Readiness Project designed to increase awareness of the profound society and fiscal impact of Alzheimer’s Disease in the United States, increase awareness about the importance of early detection, and role of biopharmaceutical companies in the search for treatments.

He serves on the Boards of a number of business associations including the German American Business Council, the American-Central European Business Association, and the Trans-Atlantic Business Council. He has been a frequent speaker and panelist on the Transatlantic Trade and Investment Partnership on both sides of the Atlantic.

Previously, he served as Associate Vice President, International at the Pharmaceutical Research and Manufacturers of America (PhRMA). His responsibilities at PhRMA included the development of pharmaceutical industry policy and advocacy related to market access barriers, government price controls, and cost-containment in developed countries.

Before joining PhRMA, David was Director of Government Affairs with the National Association for Biomedical Research (NABR), a Washington, DC-based association representing the interests of pharmaceutical and biotechnology companies, research universities, scientific societies and other institutions on the issue of laboratory animals in research. His previous experience in Washington, DC includes work in communications and market access development for the U.S. Grains Council.

Prior to moving to the United States, David worked as Manger of Media Relations at Canadian Blood Services. He previously served as the Communications Coordinator for the Progressive Conservative Caucus in the Canadian House of Commons, and as a Communications Advisor to PC Party Leaders Jean Charest, Elsie Wayne, and Joe Clark. David also worked as a City Councilor’s Assistant in the City of Nepean, and as a researcher in the Canadian House of Commons.

David has a B.Soc.Sc. from the University of Ottawa in Political Science. He is a native of Port Perry, Ontario, Canada, and resides in Washington, DC.










1615 H Street NW (at Connecticut Ave NW), Washington, DC, 20062


Metros: Farragut West (Orange/Blue/Silver); Farragut North (Red)
Click here for all transit options